Dr Steve Harr of Sana Biotechnology continues the conversation, exploring how cell therapy may transform type 1 diabetes care by targeting a one-time, curative approach to restore daily life. Watch the latest insights: https://t.co/0uW0ASURFD
#Type1Diabetes#CellTherapy
Dr Steve Harr of Sana Biotechnology continues the conversation, exploring how cell therapy may transform type 1 diabetes care by targeting a one-time, curative approach to restore daily life. Watch the latest insights: https://t.co/0uW0ASURFD
#Type1Diabetes#CellTherapy
@JeremyNguyenPhD Cool! But how about the actual workflow. where did Codex access the raw footage and what did it output as the "edit"? XML or EDL, Premiere or Resolve project, or a rendered MP4? Any other tools involved? Thx!
@BT1D_Advocacy @CT1D_Advocacy I love how clearly this paper lays out both the challenges and the pathway forward for a cure.
I also got a big dose of hope from Dr. Kowalski’s talk, and pulled together some of my fav highlights from it here. 💙 #T1D
https://t.co/ZNAPwdCoXT
10/10 “I want to be the CEO who takes off his pump.” 💙 - Dr. Kowalski. Thanks to the scientists, the advocates, the doctors and patients working on trials, I believe it will happen.
Walk. Advocate. Join a trial. #T1DStrong#DiabetesCommunity#Type1Diabetes
@genprex As a T1D advocate, I’ve followed this since Dr. Gittes’ early work. I’m grateful for Genprex’s progress. NHP data & IND prep are encouraging. Please keep prioritizing speed toward first-in-human trials. Patients are eager! #T1D#type1diabetes